Literature DB >> 2753882

Formation of active diphtheria toxin in vitro based on ligated fragments of cloned mutant genes.

S Olsnes1, H Stenmark, S McGill, E Hovig, R J Collier, K Sandvig.   

Abstract

An intact gene coding for wild type diphtheria toxin was reconstituted in vitro from fragments of cloned inactive diphtheria toxin mutants with defects in different parts of the gene. The reconstituted DNA template was amplified using the Taq DNA polymerase chain reaction, providing a virtually unlimited supply. The toxin was expressed in vitro by transcription from a T3 RNA polymerase promoter, followed by translation of the mRNA in a rabbit reticulocyte lysate system. Diphtheria toxin synthesised in this manner was shown to be as toxic as natural toxin and behaved like natural toxin in every way tested. This can serve as a general approach for study of toxic proteins, opening up the possibility of in vitro gene manipulation. Reconstitution of the wild type gene from fragments followed by polymerase chain reaction amplification bypasses the hazards of cloning protein toxins.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2753882

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

1.  Association between diphtheria toxin A- and B-fragment and their fusion proteins.

Authors:  H Stenmark; B N Afanasiev; S Ariansen; S Olsnes
Journal:  Biochem J       Date:  1992-02-01       Impact factor: 3.857

2.  Membrane translocation of diphtheria toxin carrying passenger protein domains.

Authors:  I H Madshus; S Olsnes; H Stenmark
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

3.  Amplification of protein expression in a cell free system.

Authors:  E Resto; A Iida; M D Van Cleve; S M Hecht
Journal:  Nucleic Acids Res       Date:  1992-11-25       Impact factor: 16.971

4.  Tight folding of acidic fibroblast growth factor prevents its translocation to the cytosol with diphtheria toxin as vector.

Authors:  A Wiedlocha; I H Madshus; H Mach; C R Middaugh; S Olsnes
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.